You probably know creatine as the gym staple for squats and sprints. A small new trial asked a different question: what happens in a woman's brain when she takes just 3 grams a day for four weeks? The answer is intriguing, especially for older women. It is also exploratory, and that caveat matters.
The Headline Finding
In a randomized study of 48 active women, 28 days of low-dose creatine monohydrate (3 g/day) was associated with improvements in several cognitive measures compared with placebo. The gains showed up in both young and older women. They were most consistent in:
- Visual reaction time
- Auditory reaction time
- Inhibitory control (the ability to suppress an automatic or unwanted response)
- Working memory (holding and manipulating information in your head)
The strongest statistical evidence appeared in the older women, according to the authors. Their summary points to "greater cognitive responses in older females."
Source: PubMed 42970614 | DOI: 10.1177/10998004261500758 (Biological Research for Nursing, 2026; Oliveira, Pereira, Forbes, Candow, Pires, Machado).
How the Study Worked
The researchers randomly assigned 48 women (26 young, 22 older) to either creatine monohydrate at 3 grams per day or a placebo for 28 days. Everyone completed a battery of cognitive tests before and after the supplementation period.
The team used two statistical approaches:
- Frequentist analysis with a linear mixed model and a significance threshold of p < 0.05.
- Bayesian analysis, which gauges how strongly the data support one hypothesis over another.
There was a wrinkle. The groups differed at baseline in estimated daily creatine intake from food, so the authors accounted for this in the model as a random factor. Creatine is found mainly in meat and fish, so diet can shift where someone starts.
The frequentist results were backed by what the authors describe as "moderate-to-extreme" Bayesian evidence, but only in a subset of comparisons, particularly among older women.
Why Would Creatine Affect Thinking?
The paper's rationale is that creatine supplementation can increase brain creatine levels, which may support brain bioenergetics, meaning how brain cells manage their energy supply. Better energy handling could plausibly help with demanding mental tasks over time. The authors note it has been unclear whether these benefits depend on age, which is the gap this study set out to probe.
This study measured cognitive performance, not brain creatine levels. The mechanism above is the background hypothesis, not something this trial directly demonstrated.
Why Older Women Are the Story
The most striking takeaway is not that creatine "worked" in everyone. It is that the evidence looked strongest in older women. The authors suggest this could point to a possible role for creatine in mitigating age-related cognitive decline.
The word "possible" is doing real work there. The study did not follow women over years, track dementia, or test clinical outcomes. It looked at short-term performance on cognitive tasks.
The Fine Print: Read This Before Buying a Tub
Honest flags on what this study can and cannot tell you:
- It is exploratory. The authors describe it as an "exploratory, multi-domain battery." Testing many outcomes raises the chance that some findings are noise. They explicitly call for confirmation in future, hypothesis-driven trials.
- It is small. Forty-eight participants split across four subgroups is a modest sample.
- It is short. Four weeks says nothing about long-term effects or durability.
- The women were active. The results may not extend to sedentary people or to those with cognitive impairment.
- Not every measure improved. The authors say improvements occurred in "several" parameters, "most consistently" in the domains above, and the strongest Bayesian support came in only some comparisons.
- This is human research, not animal work, but it is early-stage human research.
Practical Takeaways
Dose studied: 3 g/day of creatine monohydrate, a lower dose than the often-cited 5 g/day or loading protocols.
Duration studied: 28 days.
Timing: The abstract does not specify time of day, so there is no study-backed timing advice. Creatine is generally taken daily, and consistency is the usual priority, but that is general practice, not a finding of this paper.
Who might be interested: Active women, especially those in midlife and beyond, curious about cognitive support. Treat it as a low-dose experiment backed by promising preliminary data, not a proven brain therapy.
Who should be cautious or skip it (general guidance, not from this paper): People with kidney disease, those taking medications that affect the kidneys, and anyone pregnant or breastfeeding should talk to a clinician first. The same goes for anyone with a diagnosed memory or neurological condition. Creatine is not a replacement for medical evaluation of cognitive concerns.
What not to expect: Don't expect dramatic changes in memory or a guarantee against decline. The measured benefits were improvements on lab-style tests of reaction time, inhibition and working memory.
The Bottom Line
This trial adds a notable data point to the growing interest in creatine beyond muscle. Just 3 g/day for four weeks was associated with better performance on several cognitive measures in active women, with the clearest signals in older women. But with a small sample, a short duration and an exploratory design, it is a reason for larger, preregistered trials, not a reason to treat creatine as an established brain supplement.
References: Oliveira E, et al. Creatine Supplementation on Cognition in Young and Old Active Females. Biol Res Nurs. 2026. PubMed | DOI